Literature DB >> 12783288

Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.

Richard Crevenna1, Georg Zettinig, Mohammad Keilani, Martin Posch, Manuela Schmidinger, Christian Pirich, Martin Nuhr, Michael Wolzt, Michael Quittan, Veronika Fialka-Moser, Robert Dudczak.   

Abstract

GOALS: When thyroid and other cancers are "cured" it is often assumed that the patients are able to resume their normal lives. This was a cross-sectional study to evaluate health-related quality of life (HRQOL) and to identify rehabilitation needs of patients with non-metastatic thyroid cancer under thyroxine supplementation therapy. PATIENTS AND METHODS: Included in the study were 150 consecutive patients with differentiated thyroid cancer (age 52 +/- 14 years, range 25-83 years; male/female 39/111). All patients had a history of total thyroidectomy followed by radioiodine ablation, were free of metastatic disease and under levothyroxine treatment. The mean period since the diagnosis of thyroid cancer was 5.5 +/- 6 years (range 0-23 years). Health-related quality of life was evaluated using the SF-36 Health Survey. The findings were compared with sex- and age-matched reference values.
RESULTS: "Role-emotional" and "Vitality" were significantly lower ( P<0.001 and P<0.005, respectively) in the group as a whole ( n = 150). In the subgroup of patients with a recent (less than 1 year) diagnosis of thyroid cancer ( n = 51), however, the following subscales were significantly lower: "Mental Health" ( P<0.01), "Role-emotional" ( P<0.001), "Role-physical" ( P<0.005), "Social functioning" ( P<0.005) and "Vitality" ( P<0.001). Multiple regression analysis identified a significant positive correlation between "Mental Health", "Physical functioning", "Vitality", "Role-emotional" and "Social functioning" with the time since initial diagnosis, and there was also a positive correlation between "Physical functioning", "Bodily pain" and "Role-emotional" with male gender.
CONCLUSIONS: These findings indicate that "Vitality", "Role-physical", "Mental Health", "Role-emotional" and "Social functioning" are significantly impaired during the first year after diagnosis. Thereafter, quality of life improves correlating with the time since initial diagnosis. However, "Vitality" and "Role-emotional" remain permanently impaired in thyroid cancer patients. A multidisciplinary rehabilitation concept should include psychological support and an early start to exercise to improve physical performance of these patients leading to better HRQOL and to help them fulfill their social role earlier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783288     DOI: 10.1007/s00520-003-0474-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  51 in total

1.  Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings?

Authors:  Giovanni Capelli; Rosa I De Vincenzo; Alice Addamo; Francesco Bartolozzi; Nicola Braggio; Giovanni Scambia
Journal:  Cancer       Date:  2002-12-15       Impact factor: 6.860

2.  Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy.

Authors:  F Dimeo; S Fetscher; W Lange; R Mertelsmann; J Keul
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

3.  Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

Authors:  K H Dow; B R Ferrell; C Anello
Journal:  Thyroid       Date:  1997-08       Impact factor: 6.568

Review 4.  Quality of life among long-term cancer survivors.

Authors:  B R Ferrell; K Hassey Dow
Journal:  Oncology (Williston Park)       Date:  1997-04       Impact factor: 2.990

5.  Fatigue in the cancer patient: a conceptual approach to a clinical problem.

Authors:  J Aistars
Journal:  Oncol Nurs Forum       Date:  1987 Nov-Dec       Impact factor: 2.172

6.  A retrospective investigation of the relationship between aerobic exercise and quality of life in women with breast cancer.

Authors:  S Young-McCaughan; D L Sexton
Journal:  Oncol Nurs Forum       Date:  1991 May-Jun       Impact factor: 2.172

7.  Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.

Authors:  A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee
Journal:  J Clin Oncol       Date:  2002-11-15       Impact factor: 44.544

8.  A multifaceted rehabilitation program for women with cancer.

Authors:  J B Johnson; A W Kelly
Journal:  Oncol Nurs Forum       Date:  1990 Sep-Oct       Impact factor: 2.172

9.  Effects of aerobic interval training on cancer patients' functional capacity.

Authors:  M G MacVicar; M L Winningham; J L Nickel
Journal:  Nurs Res       Date:  1989 Nov-Dec       Impact factor: 2.381

10.  Aerobic exercise for a patient suffering from metastatic bone disease.

Authors:  R Crevenna; M Schmidinger; M Keilani; M Nuhr; V Fialka-Moser; G Zettinig; M Quittan
Journal:  Support Care Cancer       Date:  2002-11-01       Impact factor: 3.603

View more
  30 in total

1.  Quality of life-in patients with differentiated thyroid cancer at the general endocrinology clinics of the University Hospital of Puerto Rico.

Authors:  Mónica A Vega-Vázquez; Loida Gonzalez-Rodriguez; Eduardo J Santiago-Rodríguez; Anette Garcés-Domínguez; Lee-Ming Shum; Maribel Tírado-Gómez; Margarita Ramírez-Vick
Journal:  Bol Asoc Med P R       Date:  2015 Jan-Mar

2.  Health-related Quality of Life, depression and anxiety in thyroid cancer patients.

Authors:  Sefik Tagay; Stephan Herpertz; Matthias Langkafel; Yesim Erim; Andreas Bockisch; Wolfgang Senf; Rainer Görges
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Impact of surgical technique on operative morbidity and its socioeconomic benefit in thyroid surgery.

Authors:  Anita Kurmann; Forian Martens; Roman Inglin; Stefan W Schmid; Daniel Candinas; Christian A Seiler
Journal:  Langenbecks Arch Surg       Date:  2012-07-18       Impact factor: 3.445

4.  A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases.

Authors:  Katy Gallop; Cicely Kerr; Stacey Simmons; Bryan McIver; Ezra E W Cohen
Journal:  Qual Life Res       Date:  2014-08-09       Impact factor: 4.147

5.  A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.

Authors:  M Giusti; F Sibilla; C Cappi; M Dellepiane; F Tombesi; E Ceresola; C Augeri; E Rasore; F Minuto
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

6.  Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.

Authors:  Eve M Roth; Carrie C Lubitz; John Shannon Swan; Benjamin C James
Journal:  Thyroid       Date:  2020-05-14       Impact factor: 6.568

7.  Strength of skeletal muscle and quality of life in patients suffering from "typical male" carcinomas.

Authors:  Richard Crevenna; Bruno Maehr; Veronika Fialka-Moser; Mohammad Keilani
Journal:  Support Care Cancer       Date:  2009-06-12       Impact factor: 3.603

8.  Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.

Authors:  M Giusti; V Caorsi; L Mortara; M Caputo; E Monti; M Schiavo; M C Bagnara; F Minuto; M Bagnasco
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

9.  Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.

Authors:  Carrie C Lubitz; Lucia De Gregorio; Abbey L Fingeret; Konstantinos P Economopoulos; Diana Termezawi; Mursal Hassan; Sareh Parangi; Antonia E Stephen; Elkan F Halpern; Karen Donelan; J Shannon Swan
Journal:  Thyroid       Date:  2016-12-15       Impact factor: 6.568

10.  The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Authors:  Anna M Sawka; David P Goldstein; James D Brierley; Richard W Tsang; Lorne Rotstein; Shereen Ezzat; Sharon Straus; Susan R George; Susan Abbey; Gary Rodin; Mary Ann O'Brien; Amiram Gafni; Lehana Thabane; Jeannette Goguen; Asima Naeem; Lilian Magalhaes
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.